| Device-related |
Structural failure
|
Single leaflet device attachment
|
1.5%-5.1%33,34
|
|
Device embolisation
|
0.05%-0.70%33,119
|
|
Leaflet injury
|
0%-2%14,15
|
|
Functional impairment
|
Residual MR >2+
|
3.4%-17.0%14,15
|
|
Transmitral gradient >5 mmHg
|
Up to 15%15
|
| Procedure-related |
Access-site vascular
|
Major vascular complications (significant bleeding, perforation, rupture, dissection)
|
1.4%-4.0%120
|
|
Cardiac structural damage
|
Pericardial effusion or tamponade
|
0%-0.5%120
|
|
Haemodynamically relevant interatrial septal defect
|
Not consistently defined
|
|
Bleeding
|
Severe bleeding requiring blood transfusion
Possible bleeding locations: access site, pericardial effusion, gastrointestinal, urinary tract
|
0%-17%120
|
|
Thromboembolic
|
Myocardial infarction
|
0%-3%120
|
|
Stroke
|
0%-1%120
|
| MR: mitral regurgitation; M-TEER: mitral valve transcatheter edge-to-edge repair |
